New Trade (TXMD) for 1/18/2017

3:20pm (EST)

I have a New Trade on a stock that I’m expecting to test $8-$10 over the next 3-6 months. There is little coverage of the stock on Wall Street and the company has a drug in Phase 3 trials doing good things. Given the recent trading range in the market, I’m using slightly longer dated options although I’m expecting major news over the month or two on the status of the drug.


TherapeuticsMD (TXMD, $5.82, up $0.08)

Buy to Open TXMD June 7.50 calls (TXMD170616C00007500, $0.75, up $0.05)

Action: I like these call options at current levels and you can use a Limit Order up to 90 cents to get the best fills. These are the regular TXMD June 7.50 calls that expire on June 16th, 2017. I will provide the parameters of the trade in tomorrow’s Pre-Market update.